Dry Powder Inhalation Delivery of Monoclonal Antibodies
July 22, 2021
Thursday, July 22, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Local delivery of monoclonal antibodies to the lung is enabled by spray drying to manufacture stable, respirable dry powders. An inhaled formulation of bevacizumab was effective in vivo, reducing tumor burden in a rat model of non-small cell lung cancer.